STEVEN MADDEN, LTD.

Except as set forth below, during the three months ended September 30, 2026, none of the Company's directors or officers (as defined in Rule 16a-1(f) of the Exchange Act)adopted, modified, orterminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement as defined in Item 408(a) of Regulation S-K under the Exchange Act.

On August 26, 2026, Edward Rosenfeld, Chairman of the Board and Chief Executive Officer of the Company, adopted a Rule 10b5-1 trading arrangement providing for the sale, pursuant to the terms of the arrangement, of an aggregate of up to 66,000 shares of the Company’s common stock. Mr. Rosenfeld's trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of Mr. Rosenfeld’s trading arrangement is from August 26, 2026 until November 12, 2027.

On August 28, 2026, Zine Mazouzi, Chief Financial Officer and Executive Vice President of Operations of the Company, adopted a Rule 10b5-1 trading arrangement providing for the sale, pursuant to the terms of the arrangement, of an aggregate of up to 18,000 shares of the Company’s common stock. Mr. Mazouzi's trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of Mr. Mazouzi's trading arrangement is from August 28, 2026 until November 12, 2027.